Dexcom (DXCM) Current Assets (2010 - 2026)

Dexcom (DXCM) has 17 years of Current Assets data on file, last reported at $4.3 billion in Q1 2026.

• On a quarterly basis, Current Assets fell 4.88% year-over-year to $4.3 billion in Q1 2026; TTM through Mar 2026 was $4.3 billion, a 4.88% decrease from a year earlier, with the FY2025 full-year figure at $4.0 billion, down 6.23% from the prior year.
• Current Assets for Q1 2026 stood at $4.3 billion, up from $4.0 billion in the prior quarter.
• Over the last five years, Current Assets for DXCM reached as high as $5.2 billion in Q3 2025 and fell as low as $3.4 billion in Q3 2022.
• Historically, Current Assets has averaged $4.3 billion across 5 years, with a median of $4.3 billion in 2026.
• Across the five-year window, Current Assets jumped 38.25% in 2023 and declined 9.27% in 2024, its largest moves.
• Year by year, Current Assets stood at $3.7 billion in 2022, then grew by 20.64% to $4.4 billion in 2023, then declined by 2.81% to $4.3 billion in 2024, then decreased by 6.23% to $4.0 billion in 2025, then grew by 7.4% to $4.3 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $4.3 billion in Q1 2026, $4.0 billion in Q4 2025, and $5.2 billion in Q3 2025.